TENX - Tenax Therapeutics, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
7.46 0.11 (1.47%)	---	---	-0.02 (-0.26%)	---	-0.5 (-6.7%)	0.13 (1.75%)	0.13 (1.75%)

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.28
Diluted EPS:: -0.28
Basic P/E:: -27.0357
Diluted P/E:: -27.0357
RSI(14) 1m:: 0.0
VWAP:: 7.57
RVol:: 0.8129

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	7.06 -0.08 (-1.19%)	Oct 15 13:47
1m	Price increase 1m	7.22 +0.16 (+2.25%)	Oct 15 13:43
1m	Price increase 1m	7.17 +0.13 (+1.84%)	Oct 15 13:37
1m	Price decrease 1m	7.07 -0.1 (-1.39%)	Oct 15 13:29
1m	Price decrease 1m	7.26 -0.09 (-1.19%)	Oct 15 12:11